Alopecia Universalis: Never Give Up?
INTRODUCTION
Alopecia universalis is a type of alopecia areata (AA) characterized by total body hair loss. The mechanism of this loss is primarily due to autoimmune disruption of the hair follicle. AA has historically been treated with corticosteroids, minoxidil, and other immune therapies that possess limited efficacy with high recurrence rates and adverse effects.1 However, in recent years the …
INTRODUCTION
Alopecia universalis is a type of alopecia areata (AA) characterized by total body hair loss. The mechanism of this loss is primarily due to autoimmune disruption of the hair follicle. AA has historically been treated with corticosteroids, minoxidil, and other immune therapies that possess limited efficacy with high recurrence rates and adverse effects.1 However, in recent years the … 
Medical school dermatology curriculum is known for its lack of representation of images of skin of color. A letter to the editor published in the July Journal of Drugs in Dermatology shows the effects on diagnostic accuracy, perception, and confidence when one medical school took action to make its pre-clerkship dermatology curriculum more diverse.
I interviewed authors Dahyeon (Esther) Kim, a … 
The July 2025 issue of the Journal of Drugs in Dermatology brings together another outstanding selection of articles, offering cutting-edge insights and real-world strategies across a diverse range of dermatology topics. This month’s editor’s highlights spotlight innovative approaches to photoprotection in melasma and photodamage, emerging non-pharmaceutical solutions for fem … 
Welcome to another installment of our popular “From the JDD Podcast Vault” series! This week, we’re unraveling the fascinating story behind itch management with the episode: From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus, hosted by the ever-engaging Dr. Adam Friedman.
We all know that urge—“Just scratch it!” But for countless patients, chronic prurit … 
The June 2025 issue of the Journal of Drugs in Dermatology delivers a diverse and thought-provoking selection of studies that place a spotlight on acne and rosacea while spanning the latest innovations and clinical insights across the dermatology spectrum. This month’s editor’s picks feature new approaches to some of the field’s most common—and challenging—conditions, from acne-induced … 